IL6 and heart disorder: In cardiac diseases, RECK has been shown to reduce several downstream effectors of Angiotensin II (Ang-II), such as Interleukin-6 (IL-6)/IL-6 receptor (IL-6R)/glycoprotein 130 (IL-6 signal transducer) signaling [20].